BRCA Test Flaw May Affect 100 Israeli Samples
Translated & summarized from Now 14 by baba
Israel's Ministry of Health reported a malfunction in Gemidor's BRCA1 testing kit, potentially leading to 100 false negative results. Affected individuals will be contacted for further testing.
The story in 5 lines · by baba
- BRCA1 testing kit malfunction reported by Israeli Ministry of Health.
- Approximately 100 samples may have received incorrect negative results.
- Gemidor company identified and fixed the issue with its kit.
- Affected individuals will be contacted for potential re-testing.
- Over 90,000 tests were performed with the kit.
The Israeli Ministry of Health has announced a malfunction in a testing kit manufactured by Gemidor, used for detecting BRCA1 gene mutations. This malfunction has raised concerns about potentially incorrect negative results in approximately 100 samples.
In total, over 90,000 tests were conducted using the affected kit. Following the identification of the issue, all results were re-examined. Gemidor, in collaboration with genetic institutes and laboratories, identified 100 samples where a false negative result is suspected. The company has since rectified the problem with the kit.
Genetic institutes and laboratories will contact individuals whose samples are suspected of yielding incorrect results in the coming days. They may be asked to provide an additional blood sample if necessary. The Ministry of Health emphasized that individuals do not need to contact the labs themselves, as proactive outreach will be conducted for those potentially affected.
The BRCA1 gene test is a genetic screening that identifies common mutations in the BRCA1 gene. The Ministry of Health stated it will provide further updates if required.
